8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001558370-22-010491
Executive or director change · Shareholder vote results · Other events
- Item 5.02 Departure or appointment of directors or officers
- Item 5.07 Submission of matters to a vote of security holders
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading plx-20220629x8k.htm…